**Summary of Chemring Group PLCs Final Results for the Year Ended 31 October 2025**
Chemring Group PLC reported resilient financial performance for the year ended 31 October 2025, with key highlights including
1. **Revenue and Profit Growth**
Revenue increased by 2% to £497.5 million (or 3% at constant currency rates).
Underlying operating profit rose by 6% to £73.5 million, with a margin improvement to 14.8% from 14.3% in 2024.
Underlying diluted earnings per share grew by 3% to 19.4 pence.
2. **Strong Order Book**
Record order book of £1,345.4 million, up 32% from 2024, providing excellent medium-term revenue visibility.
Order intake increased by 21% to £781.4 million, driven by strong demand in Countermeasures & Energetics.
3. **Cash Performance**
Improved cash conversion of 114% (up from 103% in 2024) due to disciplined working capital management.
Net debt increased to £89.0 million (from £52.8 million in 2024) due to capital investments, with a net debt to underlying EBITDA ratio of 0.90x.
4. **Segment Performance**
**Countermeasures & Energetics**Revenue grew by 17% to £322.7 million, driven by strong performance in Energetics and operational improvements in Tennessee Countermeasures.
**Sensors & Information**Revenue declined by 18% to £174.8 million due to short-term delays in UK Government spending, but order intake increased by 19.3% to £179.3 million.
5. **Strategic Initiatives**
Acquisition of Landguard Systems to enhance and accelerate growth in Roke.
Continued investment in capacity expansion, particularly in Norway, with expected revenue and profit increases from 2028.
6. **Dividend and Shareholder Returns**
Recommended final dividend of 5.3 pence per share, up 3% from 2024, resulting in a total dividend of 8.0 pence per share.
Share buyback program ongoingwith £3.6 million spent in 2025.
7. **Outlook**
The Board expects sustained defence spending driven by geopolitical uncertainty, particularly within NATO.
Chemring is well-positioned to capitalize on this demand, with a focus on doubling annual revenue to approximately £1 billion by 2030.
Overall, Chemring Group PLC demonstrated robust performance in 2025, supported by a strong order book, strategic investments, and a favorable market environment for defence spending. The company remains committed to its growth strategy and long-term financial targets.